| P50 | author | Elísio Costa | Q37383905 |
| | Luís Belo | Q37383926 |
| | Alice Santos-Silva | Q37383948 |
| | Américo Figueiredo | Q38323082 |
| | Flávio Reis | Q38545312 |
| | Petronila Rocha-Pereira | Q42176674 |
| | Rui Pinto | Q43121437 |
| | Lina Carvalho | Q46219820 |
| | Rui Alves | Q55200621 |
| | Frederico Teixeira | Q57903181 |
| | José Sereno | Q59101499 |
| | Patrícia Garrido | Q59689619 |
| P2093 | author name string | B Parada | |
| | E Teixeira-Lemos | |
| | N Piloto | |
| P2860 | cites work | The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay | Q29616616 |
| | Chronic renal disease | Q33811203 |
| | Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition | Q34602504 |
| | Iron Deficiency and Erythropoiesis: New Diagnostic Approaches | Q35538677 |
| | Iron therapy for renal anemia: how much needed, how much harmful? | Q35650627 |
| | Sympathetic hyperactivity in chronic renal failure: a wake-up call | Q35673011 |
| | Protecting renal function in the hypertensive patient: clinical guidelines | Q36101365 |
| | Oxidative stress and antioxidant treatment in hypertension and the associated renal damage | Q36163346 |
| | Anaemia as a contributor to morbidity and mortality in congestive heart failure | Q36197978 |
| | Renal anaemia: recent developments, innovative approaches and future directions for improved management | Q36697772 |
| | Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment | Q37210837 |
| | TGF-beta signal transduction in chronic kidney disease | Q37410310 |
| | The biology of renal hypertrophy | Q38162240 |
| | Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification | Q40192794 |
| | New insights into mechanisms of blood pressure regulation in patients with uraemia | Q41109262 |
| | Atherosclerosis in Patients with End-Stage Renal Failure Prior to Initiation of Hemodialysis | Q44435941 |
| | Evaluation of two protocols of uremic rat model: partial nephrectomy and infarction | Q44689235 |
| | Effect of preventive and regressive isosorbide 5-mononitrate treatment on catecholamine levels in plasma, platelets, adrenals, left ventricle and aorta in cyclosporin A-induced hypertensive rats. | Q46544055 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 833-842 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Renal Failure | Q15762963 |
| P1476 | title | Characterization of a rat model of moderate chronic renal failure--focus on hematological, biochemical, and cardio-renal profiles | |
| P478 | volume | 31 | |